Arterial hypertension (AH) and endothelial function (EF) in patients with COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Reduced pulmonary capillary volume (Vc) is responsable for the increased alveolar exhaled nitric oxide (CA NO) in patients with progressive systemic sclerosis (PSS) and pulmonary hypertension (PH) Source: Eur Respir J 2005; 26: Suppl. 49, 561s Year: 2005
Reference values for alveolar membrane diffusion capacity and pulmonary capillary blood volume Source: Eur Respir J 2001; 18: 764-769 Year: 2001
Pulmonary arterial hypertension (PAH) in patients with lung sarcoidosis (LS) Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis Year: 2008
Studying the pulmonary capillary bed: relation between pulmonary capillary blood flow (Qs) and capillary blood volume (Vc). Data from the PROOF study Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009
Over expression of endothelin-1 (ET-1) in lung fibroblasts (LFb) from patients with pulmonary arterial hypertension (PAH), evidence for loss of inhibitory control Source: International Congress 2016 – New findings in mucosal immunology Year: 2016
Pulmonary artery pressure (PAP) is reduced by inhaled sodium nitroprusside (SNP) in an isolated lung model of pulmonary hypertension: comparison with systemic application Source: Eur Respir J 2002; 20: Suppl. 38, 4s Year: 2002
Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020
Correlation of induced sputum (IS) particles size distribution (PDS) and pulmonary function test (PFT) in asthmatics patients (A-pts) Source: Eur Respir J 2004; 24: Suppl. 48, 604s Year: 2004
Arterial partial pressure of oxygen (PaO2) - a marker for cystic fibrosis (CF) lung disease and chronic airway infection Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019
Perfused lung volume to thoracic gas volume ratio (perfused lung fraction) in subjects with COPD and controls Source: Annual Congress 2010 - State of the art imaging Year: 2010
Dead space/tidal volume ratio (VD/VT) and pulmonary function (PF) in children with obstructive acute respiratory failure (OARF) on invasive mechanical pulmonary ventilation (IMPV) Source: Eur Respir J 2004; 24: Suppl. 48, 676s Year: 2004
Total lung capacity (TLC) or vital capacity (VC) - which is more reduced in interstitial lung disease (ILD) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001
Pulmonary artery pressure (PAP) reduction by systemic and inhaled nitroglycerin (NTG) in an isolated rabbit lung model of pulmonary hypertension (PH) Source: Eur Respir J 2003; 22: Suppl. 45, 270s Year: 2003
Meaning of physiological dead space ventilation (VD/VT) increase in patients with precapillary pulmonary hypertension (PH) Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008
Lung clearance index (LCI) and trapped gas (TG) may reflect different aspects of Cystic Fibrosis (CF) lung disease in infants Source: Eur Respir J 2003; 22: Suppl. 45, 228s Year: 2003
Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 354s Year: 2006
Static lung compliance (Cst) and diffusion lung capacity (DLCO) as markers of lung function impairment in sarcoid patients with normal lung volumes Source: Eur Respir J 2003; 22: Suppl. 45, 278s Year: 2003
Bosentan treatment in pulmonary arterial hypertension (PAH) associated with interstitial lung diseases (ILDs) Source: Eur Respir J 2006; 28: Suppl. 50, 426s Year: 2006
Time-course changes in pulmonary haemodynamics in patients with idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation (LT) Source: Eur Respir J 2004; 24: Suppl. 48, 668s Year: 2004